Vistagen Appoints Cindy Anderson As Chief Financial Officer; Anderson Succeeds Jerrold Dotson Who Is Retiring After A Distinguished Decade-Long Career With Vistagen, Effective August 21, 2023
Portfolio Pulse from Happy Mohamed
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company, has announced the appointment of Cindy Anderson as Chief Financial Officer (CFO), effective August 21, 2023. Anderson, who has nearly two decades of experience in the biotechnology sector, will succeed Jerrold Dotson, who is retiring. Anderson previously served as the Chief Accounting Officer at Alnylam Pharmaceuticals and held various roles at Alexion Pharmaceuticals and Ernst & Young.
August 22, 2023 | 12:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cindy Anderson's appointment as CFO could bring fresh strategic and financial perspectives to Vistagen. Her extensive experience in the biotech sector could potentially drive the company's growth objectives.
Cindy Anderson's nearly two decades of experience in the biotech sector, including her roles at Alnylam Pharmaceuticals and Alexion Pharmaceuticals, could bring valuable insights to Vistagen. Her appointment could potentially drive the company's strategic and financial operations, and thus its growth objectives.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100